A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a chemotherapy regimen doubled the survival of patients with late-stage ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

A University of Iowa Health Care randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage ...

The study showed that patients receiving high-dose vitamin C had longer progression-free survival and nearly doubled overall survival rates, from 8.3 months in the standard care group to 16 months ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

Supplements are part of the daily routine for over half of adults in the United States. However, they aren't regulated in ...

Vitamin C is usually well tolerated, although high doses can cause diarrhea, nausea, and stomach cramps. ... What should I do if I miss a dose of a vitamin C supplement?

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing ...